http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103462962-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56f3f77865ceaebe064e8d9fb1816c5f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2013-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea1645519112429a548752301ac8a82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746a5e17338c95b5c937c510da5f80cd |
| publicationDate | 2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103462962-A |
| titleOfInvention | Application of Incarviatone A in medicaments for treating leukemia |
| abstract | The invention relates to an application of Incarviatone A in medicaments for treating leukemia, and belongs to the field of medicines. The invention relates to an application of Incarviatone A in preparation of medicaments for inhibiting leukemia cell proliferation, and an application of Incarviatone A in preparation of medicaments for inducing leukemia cell apoptosis. The Incarviatone A treats the leukemia through inhibiting leukemia cell proliferation and inducing leukemia cell apoptosis. The application of the Incarviatone A in preparation of the medicaments for treating leukemia is made public for the first time, the skeleton type is completely novel, and the Incarviatone A has an unexpectedly strong leukemia cell inhibiting activity. |
| priorityDate | 2013-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.